Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 30, 2023 - Issue 3
Submit an article Journal homepage
78
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

A novel APOA1 frameshift mutation Glu120Glyfs*60 with upper gastrointestinal involvement and an indolent course

Eli Muchtara Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]
View further author information
,
Surendra Dasarib Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA;c Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAView further author information
,
Jason D. Theisc Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAView further author information
,
Laura Ongied Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAView further author information
,
Huong T. Cabrald Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAView further author information
,
Ellen D. McPhailc Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAView further author information
,
Angela Dispenzieria Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0001-8780-9512View further author information
ORCID Icon,
Morie A. Gertza Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USAView further author information
&
Karen L. Rechc Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAView further author information
 show all
Pages 353-355 | Received 09 Nov 2022, Accepted 28 Feb 2023, Published online: 15 Mar 2023
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

Eli Muchtar received honorarium from Janssen and consultation fee from Protego (fee pain to institution). Angela Dispenzieri reports research funding from Celgene, Millennium Pharmaceuticals, Pfizer, and Janssen; and has received a travel grant from Pfizer. Morie A. Gertz M.G reports personal fees from Ionis/Akcea, Prothena, Sanofi, Janssen, Aptitude Healthgrants, Ashfield, Juno, Physicians Education Resource, Abbvie, Johnson & Johnson, Celgene, Research to Practice, and Sorrento. The remaining authors declare no competing financial interests.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.